Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin 1% versus erythromycin for anterior blepharitis
IRCT20190618043934N9Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in blepharitis comparing Azithromycin 1% topical with Erythromycin topical (2 arms). Primary endpoint: Clinical signs and symptoms of blepharitis. Started Apr 2021; status: completed.
02
Drugs
azithromycinerythromycin
03
Conditions
blepharitis
Beyond the preview
Go deeper on IRCT20190618043934N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043934N9.